Recent advances in EZH2-based dual inhibitors in the treatment of cancers
Article in European Journal of Medicinal Chemistry (May 2023)
The most recent citing publications are shown below. View all 150 publications that cite this research output on Dimensions.
Drug-induced loss of imprinting revealed using bioluminescent reporters of Cdkn1c
Article in Scientific Reports (April 2023)
EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer
Article in Cancer Letters (March 2023)